Merck KGaA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck KGaA with three other
pharmaceutical manufacturers in Europe:
sales of 5.35 billion Euros [US$6.47 billion]
of which 34%
of UNITED KINGDOM
(£20.59 billion [US$29.05 billion]
of which 41%
was Oncology), and
Novo Nordisk As
based in DENMARK
(126.95 billion Danish Kroner [US$20.67 billion]
of which 85%
was Diabetes and obesity).
During the first
quarter of 2021, sales at Merck KGaA totalled
4.63 billion Euro.
an increase of 6.0%
from the 4.37 billion Euro in sales at the company during the first quarter of 2020.
During the previous 11 quarters, sales at Merck KGaA have increased compared with the same quarter in the previous year.
Merck KGaA reported sales of 17.53 billion Euro (US$21.23 billion)
December of 2020.
increase of 8.6%
versus 2019, when the company's sales were 16.15 billion Euro.
Sales of Electronics saw an increase
that was more than double the company's growth rate: sales were up
31.3% in 2020, from
2.57 billion Euro to 3.38 billion Euro.
Not all segments of Merck KGaA experienced an increase in sales in 2020:
sales of Healthcare fell 1.1% to 6.64 billion Euro.